Literature DB >> 32232214

Potential Treatments for COVID-19; a Narrative Literature Review.

Ali Rismanbaf1.   

Abstract

SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19, which has been recognized as a pandemic by the World Health Organization (WHO) on March 11th. There is still no vaccine or definitive treatment for this virus because its pathogenesis and proliferation pathways are still unknown. Therefore, in this article, new potential COVID-19 therapies are briefly reviewed.

Entities:  

Keywords:  COVID-19; Case reports; Clinical trial; Coronavirus; Drug therapy; Review

Year:  2020        PMID: 32232214

Source DB:  PubMed          Journal:  Arch Acad Emerg Med        ISSN: 2645-4904


  33 in total

Review 1.  Cardiovascular Complications of COVID-19 and Associated Concerns: A Review.

Authors:  Wen-Liang Yu; Han Siong Toh; Chia-Te Liao; Wei-Ting Chang
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

2.  Interdisciplinary Approaches to COVID-19.

Authors:  Negar Moradian; Marjan Moallemian; Farnaz Delavari; Constantine Sedikides; Carlos A Camargo; Pedro J Torres; Armin Sorooshian; Saeid Paktinat Mehdiabadi; Juan J Nieto; Stephane Bordas; Hamid Ahmadieh; Mohammad Abdollahi; Michael R Hamblin; Frank W Sellke; Jack Cuzick; Bozkurt Biykem; Michael Schreiber; Babak Eshrati; Georg Perry; Ali Montazeri; Ali Akbar Saboury; Roya Kelishadi; Amirhossein Sahebkar; Ali A Moosavi-Movahed; Hassan Vatandoost; Mofid Gorji-Bandpy; Bahram Mobasher; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  The Main Sources and Potential Effects of COVID-19-Related Discrimination.

Authors:  Piotr Rzymski; Hanna Mamzer; Michał Nowicki
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 Mpro/3CLpro in Living Cells.

Authors:  Seyed Arad Moghadasi; Morgan A Esler; Yuka Otsuka; Jordan T Becker; Sofia N Moraes; Constance B Anderson; Srinivas Chamakuri; Christopher Belica; Chloe Wick; Daniel A Harki; Damian W Young; Louis Scampavia; Timothy P Spicer; Ke Shi; Hideki Aihara; William L Brown; Reuben S Harris
Journal:  mBio       Date:  2022-04-26       Impact factor: 7.786

5.  A review of the safety of favipiravir - a potential treatment in the COVID-19 pandemic?

Authors:  Victoria Pilkington; Toby Pepperrell; Andrew Hill
Journal:  J Virus Erad       Date:  2020-04-30

6.  Significant applications of virtual reality for COVID-19 pandemic.

Authors:  Ravi Pratap Singh; Mohd Javaid; Ravinder Kataria; Mohit Tyagi; Abid Haleem; Rajiv Suman
Journal:  Diabetes Metab Syndr       Date:  2020-05-12

7.  Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease.

Authors:  Alexander M Andrianov; Yuri V Kornoushenko; Anna D Karpenko; Ivan P Bosko; Alexander V Tuzikov
Journal:  J Biomol Struct Dyn       Date:  2020-07-14

Review 8.  Antiviral therapy in management of COVID-19: a systematic review on current evidence.

Authors:  Mahmoud Yousefifard; Alireza Zali; Kosar Mohamed Ali; Arian Madani Neishaboori; Afshin Zarghi; Mostafa Hosseini; Saeed Safari
Journal:  Arch Acad Emerg Med       Date:  2020-04-06

Review 9.  Progress in the Research and Development of Anti-COVID-19 Drugs.

Authors:  Lianzhou Huang; Yuanqiu Chen; Ji Xiao; Weisheng Luo; Feng Li; Yuan Wang; Yiliang Wang; Yifei Wang
Journal:  Front Public Health       Date:  2020-07-07

10.  COVID-19 and Unfinished Mourning.

Authors:  Behnam Farahmandnia; Lara Hamdanieh; Hamidreza Aghababaeian
Journal:  Prehosp Disaster Med       Date:  2020-05-12       Impact factor: 2.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.